Keyword: Active Pharmaceutical Ingredients (APIs)

Strategy & Management

Flow Chemistry: Key Technology for Sustainable Processes

08.04.2019 - You can call it flow chemistry or micro reaction technology (MRT) — both terms describe a technology with enormous advantages for many process engineering applications. It replaces...

News

Francesca Scarpitta Joins Cerbios as Director of HPAI Manufacturing Units

24.01.2019 -

Cerbios has appointed Francesca Scarpitta as director of the company’s high potency active ingredients (HPAIs) production units.

Chemistry & Life Sciences

DCAT Week 2019

10.01.2019 - Each year in March, the pharmaceutical manufacturing industry gathers in New York City for DCAT Week, and this year is no exception. DCAT Week ’19, the flagship event of the Drug...

News

Mallinckrodt to Split Into two Parts

12.12.2018 - Mallinckrodt Pharmaceuticals, the UK-domiciled, US-focused specialty drugmaker, plans to break up into two differentiated companies, with one focused on innovative specialty...

Markets & Companies

MENA Pharmaceutical Market

29.11.2018 - The MENA (Middle East and North Africa) region is a largely untapped, yet potentially hugely fruitful part of the world for the pharmaceutical industry, both as a sales region and...

Markets & Companies

Opportunities for Western CDMOs in China

29.11.2018 - As part of its journey toward being a full-fledged advanced economy, the role and presence of China within the pharmaceutical industry has rapidly evolved throughout the recent...

Plant Construction & Process Technology

Industry 4.0 Will Be a Game Changer for the Chemical Business

05.10.2018 - Global competition is pushing the industry towards faster time-to-market and more efficient and flexible processes. Modular plants are considered as potential bridges between the...

News

Lonza and Clovis Open New Monoplant for Ovarian Cancer Drug

04.10.2018 - Lonza and Clovis Oncology have opened a new, dedicated production train for Rubraca (rucaparib), at Lonza’s Visp site in Switzerland. Rubraca is Clovis’ US- and EU-approved drug...